androstane-3,17-diol has been researched along with Testicular Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, K; Mori, H; Nishizawa, Y; Noguchi, S; Sato, B; Takatsuka, D | 1 |
1 other study(ies) available for androstane-3,17-diol and Testicular Neoplasms
| Article | Year |
|---|---|
Formation of 5 alpha-products as major C19-steroids in estrogen-responsive mouse Leydig cell tumor lines.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstane-3,17-diol; Androstenedione; Androsterone; Animals; Estrogens; In Vitro Techniques; Leydig Cell Tumor; Male; Mice; Mice, Inbred BALB C; Progesterone; Steroid 17-alpha-Hydroxylase; Testicular Neoplasms; Testis; Testosterone | 1986 |